Gossamer Bio's total assets for Q2 2026 were $76.87M, a decrease of -40.37% from the previous quarter. DE:4GB0 total liabilities were $170.90M for the fiscal quarter, a -41.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.